Back to Media Center Clinical Collaboration Agreement Established between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding...
Back to Team Bali Muralidhar Managing Partner and Chief Investment Officer, Abingworth Bali has 15 years of professional experience in healthcare across a range of functions including venture investing, R&D, clinical practice, and teaching. He works with the team...
Back to Team Joe Bress Managing Director, U.S. Buyout, Healthcare Group, Carlyle Joe Bress is a Managing Director on the U.S. Buyout team at Carlyle, focusing on investments in the healthcare sector. He is based in New York. Since joining Carlyle in 2007, Joe has been...
Back to Team Steve Wise Partner, Managing Director and Global Head of Healthcare, Carlyle Steve Wise is a Managing Director and Head of Global Healthcare for Carlyle. He is based in New York. Since joining Carlyle in 2006, Steve has led or been a key contributor to...
Back to Team Kurt von Emster, CFA Co-Founder, Launch Therapeutics Managing Partner and Head of Abingworth Life Sciences, Abingworth Kurt joined Abingworth in January 2015, and brings over 30 years of experience in life science investment in both private and public...
